News & Events
2022-12-07
Syncell to Present New Spatial Proteomics Findings at Cell Bio 2022

Company to Showcase data generated from its novel Microscoop platform, including biomarker discovery showcasing multiple novel stress proteins

WASHINGTON DC – DECEMBER 3, 2022 – Syncell Inc., a life science company revolutionizing spatial biology research, will present at Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), showcasing its new spatial proteomics data. Using its innovative spatial proteomics system, Microscoop™, Syncell has generated groundbreaking cell biology-related biomarker discovery data. At Cell Bio 2022, the data will be categorized and presented at different sessions throughout the week in four posters. One poster that stands out in particular shows multiple novel stress granule proteins identified by Microscoop. Verified with immunostaining, the novel stress granule proteins offer high-impact data.

The Microscoop platform is an integrated optoproteomics platform for protein mapping. It is the first and only system that allows users to pick up and identify thousands of known and unknown proteins in specified cellular and subcellular locations. Researchers using Microscoop can identify novel proteins to deduce new molecular mechanisms for novel biomarkers for diagnosis and drug discovery.

Microscoop doesn’t require using a predefined antibody panel to explore morphology-based protein expression. The system uses an AI or traditional computer vision program to recognize the target cells or organelles and then applies proximity photolabeling to tag the proteins accurately in the target areas with biotin. After photolabeling, the biotinylated proteins are extracted from the samples and subjected to mass spectrometry proteome analysis.

“We’re excited to share the latest biomarker data, highlighting discoveries that are key to understanding neurodegenerative and other diseases and improving patient treatments and outcomes. This granule protein data is especially of interest and relevant for researchers who want to study proteomics of very small organelles,” said Dr. Jung-Chi Liao, Ph.D., founder and CEO of Syncell. “Microscoop has overcome the technical limitations of existing bioimage-based spatial proteomics tools that rely solely on using antibody panels to study known proteins.”

Poster Session and Booth Details:

Poster Session #1:
Day/Date of Presentation: Sunday Dec 4, 2022
Poster Session Title: Poster Session: Imaging Technologies, Single Molecule Imaging, and Super-resolution
Poster Board Number: B37
Time and Place: 12:15-1:45 PM, Exhibit Hall AB

Poster Session #2:
Day/Date of Presentation: Monday, December 5, 2022
Poster Session Title: Poster Session: Proteomics and Genomic Methods
Poster Board Number: B37
Time and Place: 12:15-1:45 PM, Exhibit Hall AB

Poster Board #3:
Day/Date of Presentation: Monday Dec 5, 2022
Poster Session Title: Poster Session: Neuronal Degeneration and Regeneration
Poster Board Number: B405
Time and Place: 12:15-1:45 PM, Exhibit Hall AB

Poster Session #4:
Day/Date of Presentation: Tuesday, December 6, 2022
Poster Session Title: Poster Session: Stress Response, Chaperones and Quality Control
Board Number: B571
Time and Place: 12:15-1:45 PM, Exhibit Hall AB
Booth Number: 1609

About Syncell Inc.
Syncell is a commercial stage life science instrument company, with a vision to revolutionize spatial biology research. Its first product, Microscoop, is the first and only microscopic bioimaging system that allows researchers to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. Syncell currently offers global customers early access to Microscoop technology through its custom service program GRASP (Global Rapid Access Service Program). Microscoop will provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, or infectious disease to identify novel biomarkers with spatial context to accelerate biomarker discovery research and drug development programs.

Contact
Lucy Lu
President, NA Operations
650-799-6638
Info@syncell.com

Website: www.syncell.com
Follow Syncell on LinkedIn and Twitter and tag your posts with #syncell or #microscoop
LinkedIn: https://www.linkedin.com/company/syncell
Twitter: https://twitter.com/IncSyncell

2022-12-07
Syncell to Present New Spatial Proteomics Findings at Cell Bio 2022

Company to Showcase data generated from its novel Microscoop platform, including biomarker discovery showcasing multiple novel stress proteins

WASHINGTON DC – DECEMBER 3, 2022 – Syncell Inc., a life science company revolutionizing spatial biology research, will present at Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), showcasing its new spatial proteomics data. Using its innovative spatial proteomics system, Microscoop™, Syncell has generated groundbreaking cell biology-related biomarker discovery data. At Cell Bio 2022, the data will be categorized and presented at different sessions throughout the week in four posters. One poster that stands out in particular shows multiple novel stress granule proteins identified by Microscoop. Verified with immunostaining, the novel stress granule proteins offer high-impact data.

The Microscoop platform is an integrated optoproteomics platform for protein mapping. It is the first and only system that allows users to pick up and identify thousands of known and unknown proteins in specified cellular and subcellular locations. Researchers using Microscoop can identify novel proteins to deduce new molecular mechanisms for novel biomarkers for diagnosis and drug discovery.

Microscoop doesn’t require using a predefined antibody panel to explore morphology-based protein expression. The system uses an AI or traditional computer vision program to recognize the target cells or organelles and then applies proximity photolabeling to tag the proteins accurately in the target areas with biotin. After photolabeling, the biotinylated proteins are extracted from the samples and subjected to mass spectrometry proteome analysis.

“We’re excited to share the latest biomarker data, highlighting discoveries that are key to understanding neurodegenerative and other diseases and improving patient treatments and outcomes. This granule protein data is especially of interest and relevant for researchers who want to study proteomics of very small organelles,” said Dr. Jung-Chi Liao, Ph.D., founder and CEO of Syncell. “Microscoop has overcome the technical limitations of existing bioimage-based spatial proteomics tools that rely solely on using antibody panels to study known proteins.”

Poster Session and Booth Details:

Poster Session #1:
Day/Date of Presentation: Sunday Dec 4, 2022
Poster Session Title: Poster Session: Imaging Technologies, Single Molecule Imaging, and Super-resolution
Poster Board Number: B37
Time and Place: 12:15-1:45 PM, Exhibit Hall AB

Poster Session #2:
Day/Date of Presentation: Monday, December 5, 2022
Poster Session Title: Poster Session: Proteomics and Genomic Methods
Poster Board Number: B37
Time and Place: 12:15-1:45 PM, Exhibit Hall AB

Poster Board #3:
Day/Date of Presentation: Monday Dec 5, 2022
Poster Session Title: Poster Session: Neuronal Degeneration and Regeneration
Poster Board Number: B405
Time and Place: 12:15-1:45 PM, Exhibit Hall AB

Poster Session #4:
Day/Date of Presentation: Tuesday, December 6, 2022
Poster Session Title: Poster Session: Stress Response, Chaperones and Quality Control
Board Number: B571
Time and Place: 12:15-1:45 PM, Exhibit Hall AB
Booth Number: 1609

About Syncell Inc.
Syncell is a commercial stage life science instrument company, with a vision to revolutionize spatial biology research. Its first product, Microscoop, is the first and only microscopic bioimaging system that allows researchers to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. Syncell currently offers global customers early access to Microscoop technology through its custom service program GRASP (Global Rapid Access Service Program). Microscoop will provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, or infectious disease to identify novel biomarkers with spatial context to accelerate biomarker discovery research and drug development programs.

Contact
Lucy Lu
President, NA Operations
650-799-6638
Info@syncell.com

Website: www.syncell.com
Follow Syncell on LinkedIn and Twitter and tag your posts with #syncell or #microscoop
LinkedIn: https://www.linkedin.com/company/syncell
Twitter: https://twitter.com/IncSyncell